Kotchetkov, R <br/><br/>
Selective cytotoxic activity of a novel ribonucleoside diphosphate reductase inhibitor MDL-101,731 against thyroid cancer in vitro.  [electronic resource] 

 -  Folia biologica  1999 
 - 185-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0015-5500 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma--pathology<br/>Carcinoma, Papillary--pathology<br/>Cell Survival--drug effects<br/>DNA Replication--drug effects<br/>DNA, Neoplasm--biosynthesis<br/>Deoxycytidine--analogs & derivatives<br/>Doxorubicin--pharmacology<br/>Drug Screening Assays, Antitumor<br/>Enzyme Inhibitors--pharmacology<br/>Fibroblasts--drug effects<br/>Flow Cytometry<br/>Humans<br/>Methotrexate--pharmacology<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-bcl-2--biosynthesis<br/>Ribonucleoside Diphosphate Reductase--antagonists & inhibitors<br/>Thyroid Neoplasms--pathology<br/>Tumor Cells, Cultured--drug effects<br/>Vincristine--pharmacology<br/>fas Receptor--biosynthesis